Form 4: Astera Labs Director Receives RSU Grant

Director Michael E. Hurlston was granted 837 restricted stock units as part of the Astera Labs, Inc. 2024 Stock Option and Incentive Plan.

Summary

• Director Michael E. Hurlston acquired 837 restricted stock units (RSUs) on June 4, 2026.
• The grant was issued under the Astera Labs, Inc. 2024 Stock Option and Incentive Plan.
• The total beneficial ownership for the director following this transaction is 92,482 shares of common stock.
• The RSUs represent a contingent right to receive one share of common stock per unit.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial outlook.

Positives

• Alignment of director interests with shareholders through equity-based compensation.

Negatives

• None identified in this filing.

Risks

• Vesting is subject to the director's continuous service relationship with the issuer.

Future Outlook

The RSUs vest in full upon the earlier of the first anniversary of the grant date or the date of the next annual stockholder meeting, provided the director maintains a continuous service relationship.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practices designed to incentivize long-term performance and align leadership with shareholder value.

Comparison to Industry Standards

• The use of RSU grants for board members is consistent with standard compensation practices for publicly traded technology companies.

Stakeholder Impact

• Minor dilution impact from the issuance of new equity, though standard for executive compensation.

Next Steps

• Vesting of the 837 RSUs on the earlier of the first anniversary of the grant date or the next annual stockholder meeting.

Key Dates

Keywords

Astera Labs, ALAB, Form 4, Insider Trading, Director Compensation, Restricted Stock Units